CYP1B1 and neoplasm: The roles of the melatonergic pathway and AhR in the tumor microenvironment are given support by recent data derived from 33 different types of solid tumors, showing the significance of increased CYP1B1 in the regulation of immune responses in the tumor microenvironment and their association with patient clinical characteristics [120].